Literature DB >> 1886045

Solubilization of aluminum-containing adjuvants by constituents of interstitial fluid.

S J Seeber1, J L White, S L Hem.   

Abstract

The solubilization of three commercially available aluminum-containing adjuvants by citrate anion was studied. Amorphous aluminum hydroxyphosphate and boehmite were both solubilized, however, amorphous aluminum hydroxyphosphate dissolved significantly faster than boehmite. The results suggest that citrate and other alpha-hydroxy carboxylate anions in the interstitial fluid are able to solubilize and thereby facilitate the excretion of aluminum from aluminum-containing adjuvants which are administered by intramuscular injection. The results also suggest that the release of antigen following administration may be significantly more rapid from an amorphous aluminum hydroxyphosphate-adjuvanted vaccine in comparison to a boehmite-adjuvanted vaccine.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1886045

Source DB:  PubMed          Journal:  J Parenter Sci Technol        ISSN: 0279-7976


  10 in total

1.  Characterization of the MN gp120 HIV-1 vaccine: antigen binding to alum.

Authors:  R P Weissburg; P W Berman; J L Cleland; D Eastman; F Farina; S Frie; A Lim; J Mordenti; T T Nguyen; M R Peterson
Journal:  Pharm Res       Date:  1995-10       Impact factor: 4.200

2.  Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.

Authors:  Karen A Near; Anthony W Stowers; Dragana Jankovic; David C Kaslow
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

3.  Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge.

Authors:  Yuhong Xiao; Yuhong Zeng; Edward Alexander; Shyam Mehta; Sangeeta B Joshi; George W Buchman; David B Volkin; C Russell Middaugh; Stuart N Isaacs
Journal:  Vaccine       Date:  2012-11-12       Impact factor: 3.641

4.  Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer.

Authors:  Daming Zhu; Shuhui Huang; Holly McClellan; Weili Dai; Najam R Syed; Elizabeth Gebregeorgis; Kelly M Rausch; Gregory E D Mullen; Carole Long; Laura B Martin; David Narum; Patrick Duffy; Louis H Miller; Allan Saul
Journal:  Vaccine       Date:  2011-11-19       Impact factor: 3.641

5.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

Review 6.  Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want.

Authors:  Harm HogenEsch; Derek T O'Hagan; Christopher B Fox
Journal:  NPJ Vaccines       Date:  2018-10-10       Impact factor: 7.344

7.  The size of micro-crystalline tyrosine (MCT®) influences its recognition and uptake by THP-1 macrophages in vitro.

Authors:  Emma Shardlow; Christopher Exley
Journal:  RSC Adv       Date:  2019-08-07       Impact factor: 4.036

8.  VaxArray immunoassay for the multiplexed quantification of poliovirus D-antigen.

Authors:  Erica D Dawson; Amber W Taylor; James E Johnson; Tianjing Hu; Caitlin McCormick; Keely N Thomas; Rachel Y Gao; Rahnuma Wahid; Kutub Mahmood; Kathy L Rowlen
Journal:  J Immunol Methods       Date:  2022-03-18       Impact factor: 2.287

9.  Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations.

Authors:  Matthew Mold; Emma Shardlow; Christopher Exley
Journal:  Sci Rep       Date:  2016-08-12       Impact factor: 4.379

Review 10.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.